R. Payan

Evaluation of a manual ELISA kit for determination of HER2/neu in serum of breast cancer patients.

D. Villemain, N. Ravanel, M. Mousseau, 2008, Anticancer research.

Tamoxifen-Induced Fluorescence as a Predictive Test for Hormone Responsiveness of Breast Carcinoma

H. Beriel, J. Mouriquand, R. Payan, 1986 .

Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.

J. Wehland, I. Treilleux, R. Margolis, 2001, Cancer research.

Prospect for anti-HER2 receptor therapy in breast cancer.

D. Fagret, N. Ravanel, M. Mousseau, 2006, Anticancer research.

Prospect for Anti-Her 2 Receptor Therapy in Breast Cancer

D. Fagret, N. Ravanel, M. Mousseau, 2008 .

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.

B. Esterni, A. Agostini, F. Penault-Llorca, 2012, Breast.

Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

M. Bolla, D. Fagret, M. Desruet, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Prognostic value of quantitative cytometry in a series of 415 T1T2/N0N1/M0 breast cancer patients--preliminary results.

M. Bolla, D. Seigneurin, M. Colonna, 1996, European journal of cancer.